Henry Journal of Cellular & Molecular Oncology

Henry Publishing Group

About the Journal

Journal of Cellular & Molecular Oncology is a peer reviewed, multidisciplinary, international open access journal which covers all aspects of cancer research including basic, preclinical, clinical, translational, molecular, epidemiological, prevention, therapy and rehabilitation. It lays an adequate basic knowledge forum for Oncologists, Physician, General Surgeons, Gynecologists, Dermatologists, Gerontologists, Pulmonologists, Radiologists, Pathologists, Epidemiologists and Researchers as Cancer research is one of the most cited fields.

Journal of Cellular & Molecular Oncology is a scientific journal which provides an opportunity to share the information among the Oncologists, medical scientists and researchers. The journal includes topics like Oncology, Chemotherapy, Radiotherapy, Breast Cancer, ovarian cancer, Lung Cancer, Brain Cancer, Surgical Oncology, Radiation Oncology, Pediatric Oncology, Tumor Cells, Hematology, Bone Marrow Transplantation, Immunotherapy, Malignant tumors, Immunobiology, pathogenesis, and treatment of malignant tumors.

Journal of Cellular & Molecular Oncology ensures the fastest publication of high quality articles with the support of its eminent Editorial board members. Two independent review comments followed by editor's decision will be considered to publish the article.

Authors may submit the manuscripts through the journal's online submission or as an e-mail attachment to oncology@henrypublishers.com

  • Antibiotics
  • Applied Biotechnology
  • Biocatalysis
  • Bioinformatics
  • Biotechnology Applications
  • Blue Biotechnology
  • Cardiovascular Biomaterials
  • Enzymes
  • Functional Genomics
  • Gene Expression
  • Gene Therapy
  • Genetic Manipulation
  • Green Biotechnology
  • Modern Biotechnology
  • Nano Biotechnology
  • Pesticides
  • Proteomics
  • Red Biotechnology
  • Structural Genomics
  • Transgenic Plants
  • White Biotechnology

Latest Articles

Evaluation of Twenty Chemical Element Contents in Thyroid Adenomas using X-Ray Fluorescent and Neutron Activation Analysis

Vladimir Zaichick*

Thyroid Adenomas (TA) are benign tumors, but there is a 20% possibility of malignant transformation. The distinguishing between the TA and Thyroid Cancer (TC) is tricky, therefore new TA biomarkers are needed. Furthermore, ....

Asymmetric Cell Division in Cancer: A Curse or a Boon?

Swastika Paul and Abhishek Dutta*

Asymmetric Cell Division (ACD) is an inherent attribute of a variety of stem cell lineages including Cancer Stem Cells (CSCs). ACD is an indispensable phenomenon required at multiple stages during the entire process of embryogenesis. ....

A Systematic Review of the Tin Content of the Normal Human Prostate Gland

Vladimir Zaichick*

The prostate gland is subject to various disorders.The etiology and pathogenesis of these diseases remain not well understood. Moreover, despite technological advancements, the differential diagnosis of prostate disorders has become ....

Burkitt's Lymphoma Revisited-A Case Report

Lokesh Rana*, Nishant Nayyar, Thakur Neeraj Kumar, Swatantra Gupta and Preyander

Burkitt Lymphoma a NON-Hodgkin's type lymphoma and is aggressive but potential curable by chemotherapy. It is commonly seen in paediatric population and imaging features can lead the diagnosis of the entity ....